This is corresponding to their prediction of patient survival outcomes with PLXNB1 showing favorable prognosis, while PLXNB3 and PLXND1 show poor prognosis for both OS and PFI in breast cancer tumors. This evidence concerns the gene PLXNB3 and breast cancer.